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Contribution of 3D gait analysis to spasticity
management in adult subjects
G. Stoquart
Cliniques universitaires Saint-Luc, Université catholique de Louvain,
Bruxelles, Belgium
The lack of knee flexion during the swing phase (stiff-knee gait) and the equi-
novarus of the foot are some of the impairments that restrict the walking ability
among patients with spastic hemiparesis. Several factors are likely to explain
these gait patterns. The most relevant factors of stiff-knee gait seem to be the
spasticity of the quadriceps (rectus femoris, vastus intermedius), the spasticity
of plantar flexors and the weakness of the iliopsoas. The quantified gait analy-
sis can help to target the treatment. For example, the botulinum toxin type A
injections in the rectus femoris alone seem sufficient to improve kinematics in
patients with a knee flexion greater than 10◦ prior to treatment, while multi-site
site injections (e.g., quadriceps, triceps surae. . .) seem necessary when the knee
flexion is lower than 10◦. The equinovarus can also be explained by various
factors (e.g., spasticity or fixed contracture of triceps surae, weakness of the
dorsal flexors and eversors. . .). The use of gait analysis is really interesting,
in association to local anesthetic motor blocks, to improve the effectiveness
of the treatment (e.g., botulinum toxin, tibial neurotomy, tendon transfers and
lengthening. . .).
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The spasticity treatments are multimodal. Rehabilitation, orthosis, diagnostic
and therapeutic nerve blocks and botulinum toxin type A (BTXa) injections are
performed by PMR specialists while intrathecal baclofen (ITB) therapy, selective
neurotomy, tendon lengthening and/or transfer and bone surgery are performed
by neurosurgeons and orthopaedic surgeons.
The first step of the neuro-orthopaedic care of the spasticity is to differen-
tiate by means of the clinical examination and of the diagnostic motor nerve
block with anaesthetics the respective contribution of the spasticity, of the
paresis and of the contracture in the patient deformity. Once the responsi-
bility of the spasticity is clearly established, a reversible treatment of the
spasticity is proposed. If a permanent treatment of the spasticity is reques-
ted, neurotomy (focal spasticity) and/or ITB therapy (generalized spasticity)
associated to tendon lengthening (contracture) and/or transfer (imbalance) are
proposed.
The large variety of available therapeutic modalities emphasizes the need for
an interdisciplinary management of the spasticity in order to perform the most
appropriate treatment for our patient. Furthermore, such interdisciplinary work
is mandatory if we want to establish practical therapeutic guidelines for the
different deformities such as elbow flexum, spastic hand, equinovarus foot, toe
claw. . .
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Acquired deforming hypertonia and
contractures in elderly subjects: Deﬁnition,
prevalence, and therapeutic options
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Bordeaux, France
The term “contractures” have often been used to describe abnormal postures
or joint deformities affecting the upper and lower limbs in dependent elderly
subjects confined to a bed or a wheelchair. However, no standard definition has
validated this term.
The lack of a standard definition explains the varying prevalence reported in the
literature. According to the different authors and criteria selected, 20 to 75%
of elderly institutionalized subjects would present at least one contracture on a
limb. Recently, a new terminology (acquired deforming hypertonia or ADH) was
suggested. ADH was defined as any joint deformity with decreased ROM and
increased resistance to passive movements, regardless of its cause, which pro-
motes functional impairments, discomfort or any other limitation in activities of
daily living. According to this new definition, the purpose of the communication
will be to present the results of the French ADH survey concerning prevalence
of ADH in geriatric institutions, and to discuss clinical characteristics, conse-
quences, ethiopathogenic factors and therapeutic options available to improve
care management for these patients.
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